持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/05/17 | 8,090 | 8,240 | 8,070 | 8,240 | +200 | +2.5% | 31,000 |
2018/05/16 | 8,000 | 8,070 | 7,980 | 8,040 | +80 | +1% | 22,100 |
2018/05/15 | 7,750 | 8,040 | 7,750 | 7,960 | +210 | +2.7% | 40,200 |
2018/05/14 | 7,580 | 7,840 | 7,440 | 7,750 | +50 | +0.6% | 46,600 |
2018/05/11 | 7,620 | 7,730 | 7,620 | 7,700 | +80 | +1% | 13,200 |
2018/05/10 | 7,730 | 7,740 | 7,590 | 7,620 | -110 | -1.4% | 20,900 |
2018/05/09 | 7,770 | 7,800 | 7,680 | 7,730 | -50 | -0.6% | 27,300 |
2018/05/08 | 7,680 | 7,850 | 7,680 | 7,780 | +10 | +0.1% | 25,300 |
2018/05/07 | 7,770 | 7,790 | 7,670 | 7,770 | +50 | +0.6% | 21,400 |
2018/05/02 | 7,750 | 7,750 | 7,640 | 7,720 | -40 | -0.5% | 12,400 |
2018/05/01 | 7,710 | 7,800 | 7,700 | 7,760 | +40 | +0.5% | 15,900 |
2018/04/27 | 7,650 | 7,740 | 7,650 | 7,720 | +90 | +1.2% | 32,700 |
2018/04/26 | 7,610 | 7,650 | 7,550 | 7,630 | +100 | +1.3% | 25,700 |
2018/04/25 | 7,420 | 7,580 | 7,380 | 7,530 | +190 | +2.6% | 33,900 |
2018/04/24 | 7,320 | 7,340 | 7,170 | 7,340 | +20 | +0.3% | 44,300 |
2018/04/23 | 7,380 | 7,380 | 7,300 | 7,320 | -100 | -1.3% | 16,300 |
2018/04/20 | 7,450 | 7,470 | 7,420 | 7,420 | -60 | -0.8% | 14,400 |
2018/04/19 | 7,390 | 7,500 | 7,390 | 7,480 | ±0 | ±0% | 16,400 |
2018/04/18 | 7,470 | 7,500 | 7,420 | 7,480 | +10 | +0.1% | 18,000 |
2018/04/17 | 7,480 | 7,600 | 7,470 | 7,470 | -160 | -2.1% | 26,100 |
2018/04/16 | 7,400 | 7,640 | 7,390 | 7,630 | +230 | +3.1% | 17,800 |
2018/04/13 | 7,470 | 7,490 | 7,390 | 7,400 | -60 | -0.8% | 22,600 |
2018/04/12 | 7,440 | 7,500 | 7,420 | 7,460 | +20 | +0.3% | 19,500 |
2018/04/11 | 7,510 | 7,540 | 7,410 | 7,440 | -110 | -1.5% | 15,700 |
2018/04/10 | 7,610 | 7,710 | 7,530 | 7,550 | -90 | -1.2% | 31,100 |
2018/04/09 | 7,770 | 7,780 | 7,630 | 7,640 | -150 | -1.9% | 26,400 |
2018/04/06 | 7,720 | 7,830 | 7,680 | 7,790 | +90 | +1.2% | 31,700 |
2018/04/05 | 7,590 | 7,750 | 7,590 | 7,700 | +170 | +2.3% | 28,200 |
2018/04/04 | 7,350 | 7,560 | 7,290 | 7,530 | +160 | +2.2% | 51,500 |
2018/04/03 | 7,470 | 7,470 | 7,310 | 7,370 | -110 | -1.5% | 49,800 |
2018/04/02 | 7,560 | 7,570 | 7,430 | 7,480 | ±0 | ±0% | 34,800 |
2018/03/30 | 7,600 | 7,600 | 7,390 | 7,480 | -40 | -0.5% | 33,800 |
2018/03/29 | 7,390 | 7,550 | 7,390 | 7,520 | +130 | +1.8% | 35,400 |
2018/03/28 | 7,320 | 7,400 | 7,180 | 7,390 | -40 | -0.5% | 24,200 |
2018/03/27 | 7,110 | 7,440 | 7,110 | 7,430 | +320 | +4.5% | 39,100 |
2018/03/26 | 7,100 | 7,170 | 7,020 | 7,110 | -60 | -0.8% | 37,900 |
2018/03/23 | 7,320 | 7,340 | 7,170 | 7,170 | -220 | -3% | 36,500 |
2018/03/22 | 7,370 | 7,400 | 7,330 | 7,390 | +30 | +0.4% | 15,700 |
2018/03/20 | 7,350 | 7,380 | 7,320 | 7,360 | -50 | -0.7% | 26,700 |
2018/03/19 | 7,400 | 7,430 | 7,370 | 7,410 | -20 | -0.3% | 14,200 |
2018/03/16 | 7,520 | 7,540 | 7,430 | 7,430 | -90 | -1.2% | 18,300 |
2018/03/15 | 7,570 | 7,590 | 7,510 | 7,520 | -50 | -0.7% | 15,900 |
2018/03/14 | 7,540 | 7,600 | 7,510 | 7,570 | -40 | -0.5% | 12,200 |
2018/03/13 | 7,530 | 7,620 | 7,490 | 7,610 | +80 | +1.1% | 22,100 |
2018/03/12 | 7,570 | 7,580 | 7,500 | 7,530 | -20 | -0.3% | 16,300 |
2018/03/09 | 7,600 | 7,650 | 7,460 | 7,550 | +60 | +0.8% | 41,100 |
2018/03/08 | 7,500 | 7,550 | 7,460 | 7,490 | +50 | +0.7% | 22,100 |
2018/03/07 | 7,470 | 7,470 | 7,400 | 7,440 | -110 | -1.5% | 35,400 |
2018/03/06 | 7,560 | 7,640 | 7,530 | 7,550 | -10 | -0.1% | 26,000 |
2018/03/05 | 7,460 | 7,600 | 7,460 | 7,560 | +100 | +1.3% | 24,000 |
1751~
1800
件表示中 / 3743件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 294,500円 | +5.1% | -7.0% | 2.72% | 19.33倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
サンバイオ | 208,100円 | - | - | 0.00% | - | 96.39倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ゼリア新薬 | 207,100円 | +3.1% | -6.5% | 2.32% | 9.61倍 | 1.02倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 149,800円 | -2.4% | -52.3% | 3.81% | 17.93倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 68,600円 | +14.3% | - | 2.92% | 27.86倍 | 1.78倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム